Biotech

All Articles

BioMarin standstills preclinical genetics treatment for heart disease

.After BioMarin performed a spring tidy of its pipeline in April, the provider has determined that i...

Eisai vegetations molecular glue SEED with $1.5 B biobucks deal

.Significant Pharmas continue to be caught to the suggestion of molecular glue degraders. The curren...

Life science credit scores agency introduces with $600M

.A brand new worldwide lifestyle scientific research credit scores organization, dubbed Symbiotic Fi...

BMS channels TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing one more major wager coming from the Caforio time, canceling...

Nuvation stops wager inhibitor after thinking about phase 1 information

.After having a look at stage 1 record, Nuvation Biography has made a decision to stop focus on its ...

' Scientific instinct' led FDA advisors to support Zevra's unusual disease med

.Zevra Therapies' rare illness medication seems to be on the path to approval this fall after obtain...

Pfizer takes $230M hit after axing failed DMD gene therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene therapy breakdown has blown a $230 thousand h...

AC Immune sees 'site' prospective in Alzheimer's drug information

.After much more than 20 years of focus on neurodegenerative health conditions, Swiss biotech air co...

GSK loses ph. 2 HPV vaccination over lack of best-in-class prospective

.GSK has junked a stage 2 human papillomavirus (HPV) vaccine from its own pipeline after determining...

OS Treatments refiles $6M IPO to money HER2 drug, preclinical ADCs

.OS Therapies will provide on the NYSE American sell substitution this morning through a $6.4 thousa...